Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Integrated PrEP and ART for Serodiscordant Couples in Kenya
NCT03052010Phase 4Completed
- Sponsor
- University of Washington
- Start
- Feb 2017
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus type 1 infection (HIV-1), sponsored by University of Washington. Started Feb 2017; status: completed.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT03052010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03052010.